Ryan Larson Ph.D.
Senior Director, Cell Therapy Product and Analytical Development, Bristol Myers Squibb
Dr. Ryan Larson has 15+ years of T cell biology and analytical technology experience. He is currently Senior Director, Cell Therapy Product & Analytical Development for Bristol Myers Squibb, Inc. He was Director, Head of Global Product Sciences at Juno Therapeutics, acquired by Celgene, acquired by BMS. Previously, Ryan was lead biologist on the flow cytometry technology and reagent development team at Thermo Fisher Scientific. Ryan has a BS degree from Saint Michael College, and a Ph.D. in immunology from the University of Washington, where he studied with Steven Ziegler. Ryan has contributed to the development and commercialization of two gene-engineered T cell therapies as well as multiple first-in-human clinical studies.